Comprehensive assessment of Cardiovascular-Kidney-Metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients (2024)

Table of Contents
Comprehensive assessment of Cardiovascular-Kidney-Metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients Article available in PDF format

open access

View PDF

Download PDF file

Supp./Additional Files

Page views 21

Article views/downloads 7

Get Citation

Comprehensive assessment of Cardiovascular-Kidney-Metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients

Krzysztof Batko1, Anna Sączek2, Małgorzata Banaszkiewicz2, Jolanta Małyszko3, Ewa Koc-Żórawska4, Marcin Żórawski56, Karolina Niezabitowska2, Katarzyna Siek2, Alina Bętkowska-Prokop2, Jacek A Małyszko7, Marcin Krzanowski2, Katarzyna Krzanowska2

'); var $authorName = $('

').appendTo($authorBox); $authorName.html($span.find(".author-name").html()); if ($span.find(".orcid-link").length) { var $orcid = $span.find(".orcid-link"); $orcid.clone().appendTo($authorBox).append($('' + $orcid.attr("data-orcid-id") + '')); } $span.find("sup").each(function() { var $affiliation = $(this); $('

' + $affiliation.attr("title").trim() + '

').appendTo($authorBox); }); new _v.tooltips.tooltip($a, $authorBox, {class: 'affiliationInBox', positionParams: {offsetTop: 10}}); return false; }); });

Article available in PDF format

View PDF

Download PDF file

References

  1. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011; 305(15): 1545–1552.
  2. Feng X, Hou N, Chen Z, et al. Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019. BMJ Open. 2023; 13(3): e064540.
  3. Małyszko J, Bachorzewska-Gajewska H, Tomaszuk-Kazberuk A, et al. Cardiovascular disease and kidney transplantation‑evaluation of potential transplant recipient. Pol Arch Med Wewn. 2014; 124(11): 608–616.
  4. Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. 2019; 32(3): 389–399.
  5. Nano J, Schöttker B, Lin JS, et al. Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population. Nephrol Dial Transplant. 2022; 37(10): 1916–1926.
  6. Ndumele CE, Rangaswami J, Chow SL, et al. American Heart Association. Cardiovascular-Kidney-Metabolic health: a presidential advisory from the american heart association. Circulation. 2023; 148(20): 1606–1635.
  7. Jung YuJ, Lee JE, Lee AeS, et al. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem Biophys Res Commun. 2012; 419(2): 206–210.
  8. Kim DH, Jung YuJ, Lee JE, et al. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol. 2011; 301(2): F427–F435.
  9. Hosoda R, Nakashima R, Yano M, et al. Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice. J Pharmacol Sci. 2023; 152(2): 112–122.
  10. Gu C, Xing Y, Jiang Li, et al. Impaired cardiac SIRT1 activity by carbonyl stress contributes to aging-related ischemic intolerance. PLoS One. 2013; 8(9): e74050.
  11. Vachharajani VT, Liu T, Wang X, et al. Sirtuins link inflammation and metabolism. J Immunol Res. 2016; 2016.
  12. Lu CL, Liao MT, Hou YC, et al. Sirtuin-1 and Its Relevance in Vascular Calcification. Int J Mol Sci. 2020; 21(5): 1593.
  13. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010; 120(4): 1056–1068.
  14. Kida Y, Zullo JA, Goligorsky MS. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation. Biochem Biophys Res Commun. 2016; 478(3): 1074–1079.
  15. Huang XZ, Wen D, Zhang M, et al. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. J Cell Biochem. 2014; 115(5): 996–1005.
  16. Zhao L, Leung LL, Morser J. Chemerin forms: their generation and activity. Biomedicines. 2022; 10(8): 2018.
  17. Mariani F, Roncucci L. Chemerin/chemR23 axis in inflammation onset and resolution. Inflamm Res. 2015; 64(2): 85–95.
  18. Behnoush AH, Shobeiri P, Bahiraie P, et al. Chemerin levels in chronic kidney disease: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023; 14.
  19. Mocker A, Hilgers KF, Cordasic N, et al. Renal chemerin expression is induced in models of hypertensive nephropathy and glomerulonephritis and correlates with markers of inflammation and fibrosis. Int J Mol Sci. 2019; 20(24): 6240.
  20. Lin S, Teng J, Li J, et al. Association of chemerin and vascular endothelial growth factor (VEGF) with diabetic nephropathy. Med Sci Monit. 2016; 22: 3209–3214.
  21. Ferland DJ, Mullick AE, Watts SW. Chemerin as a driver of hypertension: a consideration. Am J Hypertens. 2020; 33(11): 975–986.
  22. Bekcer GJ, Wheeler DC, Zeeuw DD, et al. Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney International Supplements. 2012; 2(5): 337–414.
  23. Mach F, Baigent C, Catapano AL, et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1): 111–188.
  24. Pattaro C, Riegler P, Stifter G, et al. Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association. Nephron Clin Pract. 2013; 123(1-2): 102–111.
  25. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic KidneyDisease. Kidney Int. 2021; 99(3S): S1–S87.
  26. SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42(25): 2439–2454.
  27. Rangaswami J, Mathew RO, Parasuraman R, et al. Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant. 2019; 34(5): 760–773.
  28. Aziz F, Jorgenson M, Garg N, et al. New approaches to cardiovascular disease and its management in kidney transplant recipients. Transplantation. 2022; 106(6): 1143–1158.
  29. Zbroch E, Bazyluk A, Malyszko J, et al. The serum concentration of anti-aging proteins, sirtuin1 and αKlotho in patients with end-stage kidney disease on maintenance hemodialysis. Clin Interv Aging. 2020; 15: 387–393.
  30. Łukawska-Tatarczuk M, Franek E, Czupryniak L, et al. Sirtuin 1, Visfatin and IL-27 Serum Levels of Type 1 Diabetic Females in Relation to Cardiovascular Parameters and Autoimmune Thyroid Disease. Biomolecules. 2021; 11(8): 1110.
  31. Yue XG, Yang ZG, Zhang Y, et al. Correlations between SIRT1 gene polymorphisms and diabetic kidney disease. R Soc Open Sci. 2018; 5(6): 171871.
  32. Kedenko L, Lamina C, Kedenko I, et al. Genetic polymorphisms at SIRT1 and FOXO1 are associated with carotid atherosclerosis in the SAPHIR cohort. BMC Med Genet. 2014; 15: 112.
  33. Bielach-Bazyluk A, Zbroch E, Czajkowska K, et al. Serum sirtuin 1is independently associated with intact PTH among patients with chronic kidney disease. Clin Interv Aging. 2021; 16: 525–536.
  34. Krekora J, Matuszewska-Brycht O, Sołek J, et al. Sirtuin 1 and Sirtuin 2 Plasma Concentrations in Patients with AscendingAortic Dissection and Ascending Aortic Aneurysm. Artery Res. 2023; 29(3): 79–82.
  35. Esmayel IM, Hussein S, Gohar EA, et al. Plasma levels of sirtuin-1 in patients with cerebrovascular stroke. Neurol Sci. 2021; 42(9): 3843–3850.
  36. Doulamis IP, Tzani AI, Konstantopoulos PS, et al. A sirtuin 1/MMP2 prognostic index for myocardial infarction in patients with advanced coronary artery disease. Int J Cardiol. 2017; 230: 447–453.
  37. Shao Y, Ren H, Lv C, et al. Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine. 2017; 55(1): 130–138.
  38. Wang D, Yuan GY, Wang XZ, et al. Plasma chemerin level in metabolic syndrome. Genet Mol Res. 2013; 12(4): 5986–5991.
  39. Yoo HJ, Choi HY, Yang SJ, et al. Circulating chemerin level is independently correlated with arterial stiffness. J Atheroscler Thromb. 2012; 19(1): 59–68.
  40. Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med. 2011; 50(10): 1093–1097.
  41. Hu W, Feng P. Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients. Diabetes Res Clin Pract. 2011; 91(2): 159–163.
  42. Blaszak J, Szolkiewicz M, Sucajtys-Szulc E, et al. High serum chemerin level in CKD patients is related to kidney function, but not to its adipose tissue overproduction. Ren Fail. 2015; 37(6): 1033–1038.
  43. Rutkowski P, Sledzinski T, Zielinska H, et al. Decrease of serum chemerin concentration in patients with end stage renal disease after successful kidney transplantation. Regul Pept. 2012; 173(1-3): 55–59.
  44. Szramowska A, Bielecki M, Grzeszczyk M, et al. High-sensitivity cardiac troponin T in detecting obstructive coronary artery disease in hemodialysis patients listed for kidney transplantation. Kardiol Pol. 2024; 82(3): 285–291.
  45. Bellasi A, Salera D, Ratti C, et al. Cardiovascular screening in chronic kidney disease subjects waiting for transplantation: Unresolved question. Pol Heart J. 2024; 82(4): 474–476.
  46. Szramowska A, Bielecki M, Grzeszczyk M, et al. High-sensitivity cardiac troponin T in detecting obstructive coronary artery disease in hemodialysis patients listed for kidney transplantation. Pol Heart J. 2024; 82(3): 285–291.
  47. Stompór T, Winiarska A. Kidneys in heart failure: Impact of flozins. Kardiol Pol. 2023; 81(11): 1071–1080.

') .append($($headInfo.html())) .insertBefore($('.articleTitle')) ; }); })();

This site uses cookies

We use cookies on our website. We use them to ensure the proper functioning of the site and, if you give us your consent, for purposes we set, such as analytics or marketing. We would like to ask your permission to store them on your device. We will not run optional cookies until you have enabled them yourself. If you would like to learn more about how cookies work and how we process personal data related to them, please visit our Privacy Policy page

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisem*nts based on your previous activities within our website.

Comprehensive assessment of Cardiovascular-Kidney-Metabolic (CKM) syndrome: Novel tools for assessment of cardiovascular risk and kidney outcomes in long-term kidney transplant patients (2024)
Top Articles
Tragic Loss: How Sue Aikens' Beloved Granddaughter Lost Her Life
Is Jasmine Crockett A Mother?
Tower Of Trample Walkthrough
The Family of Mary J. Blige: Ex-Husband, Siblings, Parents - BHW
Costco Wholesale in Strongsville
You Might Want to Upgrade to the Costco Executive Membership. Here's Why
Round Valley Online Yard Sale
Ja'marr Chase Lipstick Alley
Used Outdoor Dog Kennels For Sale Craigslist
what are the most beautiful places in Switzerland?
Latest Posts
Tragic Loss: Unveiling The Age Of Luke Combs' Brother At Time Of Passing
Eric Clapton's Son's Tragic Death: A Heartbreaking Story Of Loss
Article information

Author: Greg Kuvalis

Last Updated:

Views: 5932

Rating: 4.4 / 5 (55 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Greg Kuvalis

Birthday: 1996-12-20

Address: 53157 Trantow Inlet, Townemouth, FL 92564-0267

Phone: +68218650356656

Job: IT Representative

Hobby: Knitting, Amateur radio, Skiing, Running, Mountain biking, Slacklining, Electronics

Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.